Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Angiotensin II (Ang II) is both a vasoactive and a potent growth-promoting factor for vascular smooth muscle cells. Little is known about the in vivo contribution of AT1 and AT2 receptor activation to the biological action of Ang II. Therefore, we investigated the effect of AT1 or AT2 subtype receptor chronic blockade by losartan or PD123319 on the vascular hypertrophy in rats with Ang II-induced hypertension. Normotensive rats received for 3 wk subcutaneous infusions of Ang II (120 ng/kg per min), or Ang II + PD 123319 (30 mg/kg per d), or Ang II + losartan (10 mg/kg per d) or PD 123319 alone, and were compared with control animals. In normotensive animals, chronic blockade of AT2 receptors did not affect the plasma level of angiotensin II and the vascular reactivity to angiotensin II mediated by the AT1 receptor. Chronic blockade of AT1I in rats receiving Ang II resulted in normal arterial pressure, but it induced significant aortic hypertrophy and fibrosis. Chronic blockade of AT2 receptors in Ang II-induced hypertensive rats had no effect on arterial pressure, but antagonized the effect of Ang II on arterial hypertrophy and fibrosis, suggesting that in vivo vasotrophic effects of Ang II are at least partially mediated via AT2 subtype receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baltosser, W. H., & Zar, J. H. (1996) · Ecology · doi:10.2307/2265725 · Cited by 35,166
Image analysis and mathematical morphology
(1982) · Computer Graphics and Image Processing · doi:10.1016/0146-664x(82)90078-8 · Cited by 8,151
Zar, J. H. (1996) · Cited by 7,837
Image Analysis and Mathematical Morphology.
Diggle, P. J., & Serra, J. (1983) · Biometrics · doi:10.2307/2531038 · Cited by 3,894
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.
Pignoli, P., Tremoli, E., Poli, A., Oreste, P., & Paoletti, R. (1986) · Circulation · doi:10.1161/01.cir.74.6.1399 · Cited by 2,404 · cited 1×
“terior and posterior wall was obtained (25, 26).”
MethodAngiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.
Geisterfer, A. A., Peach, M. J., & Owens, G. K. (1988) · Circulation Research · doi:10.1161/01.res.62.4.749 · Cited by 1,065
Stoll, M., Steckelings, U. M., Paul, M., Bottari, S. P., Metzger, R., & Unger, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117710 · Cited by 906 · cited 1×
“(44) demonstrated that the angiotensin AT2 receptor mediates inhibition of cultured endothelial cells and, in a recent study by Yamada et al.”
BackgroundAngiotensin II type 2 receptor mediates programmed cell death.
Yamada, T., Horiuchi, M., & Dzau, V. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.156 · Cited by 697 · cited 1×
“(45), AT2 receptors favored apoptosis in a rat pheochromocytoma cell line.”
BackgroundBrilla, C. G., Zhou, G., Matsubara, L., & Weber, K. T. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1098 · Cited by 694 · cited 1×
“(58) reported, in cultured adult rat cardiac fibroblasts, that Ang II stimulates collagen synthesis by both AT1 and AT2 receptors and that Ang II inhibition of collagenase activity is specifically mediated by the AT2 subtype receptor.”
BackgroundNakajima, M., Hutchinson, H. G., Fujinaga, M., Hayashida, W., Morishita, R., Zhang, L., Horiuchi, M., Pratt, R. E., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10663 · Cited by 680
Cited by
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Intengan, H. D., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.096249 · Cited by 979
Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases
Matsubara, H. (1998) · Circulation Research · doi:10.1161/01.res.83.12.1182 · Cited by 478
Recent Progress in Angiotensin II Type 2 Receptor Research in the Cardiovascular System
Horiuchi, M., Akishita, M., & Dzau, V. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.613 · Cited by 473
Drugs targeting the renin–angiotensin–aldosterone system
Zaman, M. A., Oparil, S., & Calhoun, D. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd873 · Cited by 439
AT2Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism
Gohlke, P., Pees, C., & Unger, T. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.349 · Cited by 395
Expression of the Subtype 2 Angiotensin (AT2) Receptor Protein in Rat Kidney
Ozono, R., Wang, Z.-Q., Moore, A. F., Inagami, T., Siragy, H. M., & Carey, R. M. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1238 · Cited by 317
Karnik, S. S., Unal, H., Kemp, J. R., Tirupula, K. C., Eguchi, S., Vanderheyden, P. M. L., & Thomas, W. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010454 · Cited by 302
Ichihara, S., Senbonmatsu, T., Price, E., Ichiki, T., Gaffney, F. A., & Inagami, T. (2001) · Circulation · doi:10.1161/01.cir.104.3.346 · Cited by 299
The renin-angiotensin system and malignancy
Ager, E. I., Neo, J., & Christophi, C. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn171 · Cited by 295
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide
Berry, C., Touyz, R., Dominiczak, A. F., Webb, R. C., & Johns, D. G. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.6.h2337 · Cited by 259
Robert, V., Heymes, C., Silvestre, J.-S., Sabri, A., Swynghedauw, B., & Delcayre, C. (1999) · Hypertension · doi:10.1161/01.hyp.33.4.981 · Cited by 230
Self-citationAngiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy
Shihab, F. S., Bennett, W. M., Tanner, A. M., & Andoh, T. F. (1997) · Kidney International · doi:10.1038/ki.1997.380 · Cited by 209
Angiotensin II attenuates renal cortical cyclooxygenase-2 expression
Cheng, H.-F., Wang, J.-L., Zhang, M.-Z., Miyazaki, Y., Ichikawa, I., McKanna, J. A., & Harris, R. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5505 · Cited by 200
“The AT2R antagonist PD123319 (30 mg/kg/day) (20) was administered by miniosmotic pump (Alza Pharmaceuticals, Mountain View, California, USA) for 7 days.”
Ma, J., Nishimura, H., Fogo, A., Kon, V., Inagami, T., & Ichikawa, I. (1998) · Kidney International · doi:10.1111/j.1523-1755.1998.00893.x · Cited by 168
“In this context, AT2 might be involved in tissue remodeling or repair under some pathophysiological circumstances, although the results of in vitro studies on vasculatures, cardiac tissues, and cultured fibroblasts are still controversial [27–32].”
ResultMolecular mechanisms of angiotensin II-induced vascular injury
Ruiz-Ortega, M., Ruperez, M., Esteban, V., & Egido, J. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0014-0 · Cited by 163
“In VSMC, AT2 stimulation increases collagen synthesis via Gi proteins [11], however, its role in trophic effects on VSMC in vivo is controversial [12, 13 ].”
BackgroundThe Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target
Steckelings, U. M., Widdop, R. E., Sturrock, E. D., Lubbe, L., Hussain, T., Kaschina, E., Unger, T., Hallberg, A., Carey, R. M., & Sumners, C. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000281 · Cited by 97
Metadata
- Authors
- Levy, B. I., Benessiano, J., Henrion, D., Caputo, L., Heymes, C., Duriez, M., Poitevin, P., & Samuel, J. L.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-07-15
- Volume
- 98
- Issue
- 2
- Pages
- 418-425
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2045075125
- Cited by
- 233
- References
- 41
- FWCI
- 17.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.